Topical HDAC Inhibitor Reduced BCC Size in Early Study Topical HDAC Inhibitor Reduced BCC Size in Early Study

Surgical excision is the preferred treatment for BCC, but there is still a need for noninvasive treatment options, the investigator pointed out.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Dermatology News Source Type: news